Sphingolipid, fatty acid and phospholipid metabolites are associated with disease severity and mTOR inhibition in lymphangioleiomyomatosis. (2020)
Attributed to:
Design for Additive Manufacturing (D4AM)
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/thoraxjnl-2019-214241
PubMed Identifier: 32467337
Publication URI: http://europepmc.org/abstract/MED/32467337
Type: Journal Article/Review
Volume: 75
Parent Publication: Thorax
Issue: 8
ISSN: 0040-6376